Real's June Agent Survey: Buyer Power Grows as Market Remains Subdued
MIAMI — The Real Brokerage Inc. (NASDAQ: REAX, 'Real'), a leading real estate technology platform redefining the industry through innovation and culture, today released results from its June 2025 Agent Survey. The data points to ongoing market trends: increasing buyer leverage and a continued decline in transaction activity compared to 2024. While agents remain optimistic about the potential for market improvement over the next year, affordability remains a key concern amid sticky mortgage rates and home prices near all-time highs.
Article content
This month's survey also highlights the rapid adoption of Artificial Intelligence (AI) as a productivity driver among real estate agents. Fifty-eight percent (58%) of agents reported using AI tools daily — a notable increase from approximately 50% last year, with the primary use cases concentrated in marketing and content creation.
Article content
'Our June survey shows a continued moderation in transaction volume, leading to an even more buyer-friendly market,' said Tamir Poleg, Chairman and CEO of Real. 'In a challenging market, agents are increasingly leveraging AI in their daily workflows to innovate and improve efficiency.'
'The survey results reinforce the industry's demand for advanced technology tools, validating our strategic focus on a comprehensive, AI-powered platform,' said Pritesh Damani, Chief Technology Officer at Real. 'While the survey shows that the primary use cases for AI used by agents today are predominantly focused on marketing, our vision extends much further. At Real, we are actively building technology to empower every part of the transaction workflow, from initial discovery and client engagement to the complexities of negotiation and the final close.'
Article content
Key Survey Findings: Market Trends and Insights
Article content
Transaction Growth Index Shows Modest Improvement from May: Real's Transaction Growth Index, which tracks agent-reported year-over-year changes in home-sales activity within their local markets, rose to 46.2 in June, a modest improvement from 44.2 in May. This improved index suggests the pace of decline in local market activity was more moderate in June than in May. (Note: This index reflects agents' perceptions of local market trends and is not indicative of Real's company-specific transaction volume. Scores are weighted on a 0-100 point scale, with scores above 50 indicating year-over-year growth and scores below 50 signaling a decline.) In the U.S., the subindex was 44.8, compared to 43.9 in May. Meanwhile, Canada's index reading was 59.6, up from 46.7.
Overall, 45% of agents saw fewer transactions take place in their markets this June compared to June 2024 (including 7% who saw significantly fewer transactions), while 23% saw an increase in transactions. Twenty-nine percent (29%) of agents reported transaction activity that was approximately flat year-over-year.
Agent Optimism Remains Resilient: Real's Agent Optimism Index, which measures agents' 12-month outlook for their local markets, grew slightly to 59.5 in June from 57.0 in May. While a reading above 50 indicates net optimism, overall sentiment remains similar to this time last year. Still, 48% of agents felt more optimistic in June (including 10% who felt significantly more optimistic) compared to May.
Buyer Power Strengthens Across Markets: In June, 48% of agents said their local market favors buyers, marking an increase from 43% in May. Only 26% said it favored sellers, and 26% described conditions as balanced. Agents also noted increasing inventory, longer times on the market and greater room for negotiation as signals of this ongoing power shift.
Affordability and Economic Concerns Persist for Buyers: Affordability was again the top challenge facing buyers, cited by 51% of agents. Economic uncertainty also remains a significant barrier, with 26% of agents citing it as the top challenge for buyers, only slightly down from 28% in May. Inventory constraints (16%) and buyer competition (5%) were seen as lesser issues.
Article content
A full summary of these results can be found on Real's investor relations website at https://investors.onereal.com/.
Article content
About the Survey
Article content
The Real Brokerage June 2025 Agent Survey included responses from over 140 real estate agents across the United States and Canada and was conducted between June 30, 2025 and July 15, 2025. Responses to questions regarding transaction growth and agent optimism were calibrated on a 0-100 point index scale, with readings above 50 indicating an improving trend, whereas readings below 50 indicate a declining trend. Responses are meant to capture industry-level information and are not meant to serve as an indication of Real's company-specific growth trends. Additionally, given the smaller sample size, there can be greater variability in Canada index results on a month-to-month basis.
Article content
About Real
Article content
Real (NASDAQ: REAX) is a real estate experience company working to make life's most complex transaction simple. The fast-growing company combines essential real estate, mortgage and closing services with powerful technology to deliver a single seamless end-to-end consumer experience, guided by trusted agents. With a presence in all 50 states throughout the U.S. and Canada, Real supports over 28,000 agents who use its digital brokerage platform and tight-knit professional community to power their own forward-thinking businesses.
Article content
Forward-Looking Information
Article content
This press release contains forward-looking information within the meaning of applicable Canadian securities laws. Forward-looking information is often, but not always, identified by the use of words such as 'seek', 'anticipate', 'believe', 'plan', 'estimate', 'expect', 'likely' and 'intend' and statements that an event or result 'may', 'will', 'should', 'could' or 'might' occur or be achieved and other similar expressions. These statements reflect management's current beliefs and are based on information currently available to management as of the date hereof. Forward-looking information in this press release includes, without limiting the foregoing, expectations regarding the residential real estate market in the U.S. and Canada.
Article content
Forward-looking information is based on assumptions that may prove to be incorrect, including but not limited to expectations regarding 2025 market conditions. Real considers these assumptions to be reasonable in the circumstances. However, forward-looking information is subject to known and unknown risks, uncertainties and other factors that could cause actual results, performance or achievements to differ materially from those expressed or implied in the forward-looking information. Important factors that could cause such differences include, but are not limited to, slowdowns in real estate markets and economic and industry downturns, and those risk factors discussed under the heading 'Risk Factors' in the Company's Annual Information Form dated March 6, 2025, and 'Risks and Uncertainties' in the Company's Quarterly Management's Discussion and Analysis for the period ended March 31, 2025, copies of which are available under the Company's SEDAR+ profile at www.sedarplus.ca. These factors should be carefully considered and readers should not place undue reliance on the forward-looking statements. Although the forward-looking statements contained in this press release are based upon what management believes to be reasonable assumptions, Real cannot assure readers that actual results will be consistent with these forward-looking statements. These forward-looking statements are made as of the date of this press release, and Real assumes no obligation to update or revise them to reflect new events or circumstances, except as required by law.
Article content
Article content
Article content
Article content
Contacts
Article content
Investor inquiries, please contact:
Ravi Jani
Chief Financial Officer
investors@therealbrokerage.com
908.280.2515
Article content
Article content
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Globe and Mail
6 minutes ago
- Globe and Mail
S&P 500 sinks 1.6%, its worst drop since May, following surprisingly weak hiring numbers and Trump's tariff rollout
NEW YORK (AP) — S&P 500 sinks 1.6%, its worst drop since May, following surprisingly weak hiring numbers and Trump's tariff rollout.
Globe and Mail
6 minutes ago
- Globe and Mail
Tevogen CEO Affirms Strong Growth, Capital Position, and AI Expansion in Letter to Stockholders
WARREN, N.J., Aug. 01, 2025 (GLOBE NEWSWIRE) -- Tevogen ('Tevogen Bio Holdings Inc.' or 'Company') (Nasdaq: TVGN), today released a letter to stockholders. Dear Fellow Stockholders, Tevogen has rapidly evolved from a biotechnology innovator into a dynamic enterprise expanding into artificial intelligence through Our mission remains steadfast: delivering clinically impactful, economically accessible therapies by leveraging cutting-edge science and technology. Tevogen has become a recognized name for its business philosophy of social responsibility, patient affordability and cost efficiency. In under five years, we validated our proprietary ExacTcell™ platform, completed successful proof-of-concept clinical trial of the platforms first product, established drug discovery R&D center — currently in the process of establishing our own GMP cell manufacturing facility, expanded corporate infrastructure, built a robust intellectual property portfolio, and established one of the pioneering AI initiatives in the industry — assets of significant value, while maintaining 74% insider equity ownership. With the successful launch of our proprietary AI-driven PredicTcell™ platform, we've significantly enhanced target discovery efficiency. Strategic partnerships with global technology leaders, such as Microsoft and Databricks, have accelerated our progress. Recent patent filings further secure our intellectual property in AI-driven predictive modeling, positioning us at the forefront of innovation. Importantly, Tevogen Bio is well capitalized, having access to necessary funding we may require to fully execute our current growth strategy, including the accelerated development of While the sector faces significant challenges, our company continues to grow, underscoring the foundational strength of our company. We deeply appreciate your continued support as we work toward our vision of transforming healthcare through democratizing access. It feels good to be part of this growth story and am grateful to my colleagues at Tevogen for their exceptional expertise, dedication, and, above all, their compassion for others. Sincerely, Ryan Saadi, MD, MPH Founder and CEO, Tevogen Bio Recent Announcements Tevogen Highlights 74% Insider Ownership, Reinforcing Long-Term Vision Tevogen Signs Letter of Intent for New In-House Cell Therapy Manufacturing Facility Builds Alpha Version of PredicTcell Model with Microsoft and Databricks; Observes Drastic Time Reduction in Target Analysis Translating to Potential Savings of Billions in Drug Development Costs Tevogen's New Headquarters, Fully Funded by CEO, Centralizes R&D and AI Teams to Accelerate Innovation Forward-Looking Statements This press release contains certain forward-looking statements, including without limitation statements relating to: Tevogen's plans for its research and manufacturing capabilities; expectations regarding future growth; expectations regarding the healthcare and biopharmaceutical industries; and Tevogen's development of, the potential benefits of, and patient access to its product candidates for the treatment of infectious diseases and cancer. Forward-looking statements can sometimes be identified by words such as 'may,' 'could,' 'would,' 'expect,' 'anticipate,' 'possible,' 'potential,' 'goal,' 'opportunity,' 'project,' 'believe,' 'future,' and similar words and expressions or their opposites. These statements are based on management's expectations, assumptions, estimates, projections and beliefs as of the date of this press release and are subject to a number of factors that involve known and unknown risks, delays, uncertainties and other factors not under the company's control that may cause actual results, performance or achievements of the company to be materially different from the results, performance or other expectations expressed or implied by these forward-looking statements. Factors that could cause actual results, performance, or achievements to differ from those expressed or implied by forward-looking statements include, but are not limited to: that Tevogen will need to raise additional capital to execute its business plan, which may not be available on acceptable terms or at all; changes in the markets in which Tevogen competes, including with respect to its competitive landscape, technology evolution, or regulatory changes; changes in domestic and global general economic conditions; the risk that Tevogen may not be able to execute its growth strategies or may experience difficulties in managing its growth and expanding operations; the risk that Tevogen may not be able to develop and maintain effective internal controls; the failure to achieve Tevogen's commercialization and development plans and identify and realize additional opportunities, which may be affected by, among other things, competition, the ability of Tevogen to grow and manage growth economically and hire and retain key employees; the risk that Tevogen may fail to keep pace with rapid technological developments to provide new and innovative products and services or make substantial investments in unsuccessful new products and services; risks related to the ability to develop, license or acquire new therapeutics; the risk of regulatory lawsuits or proceedings relating to Tevogen's business; uncertainties inherent in the execution, cost, and completion of preclinical studies and clinical trials; risks related to regulatory review, approval and commercial development; risks associated with intellectual property protection; Tevogen's limited operating history; and those factors discussed or incorporated by reference in Tevogen's Annual Report on Form 10-K. You should not place undue reliance on forward-looking statements, which speak only as of the date they are made. Tevogen undertakes no obligation to update any forward-looking statements, except as required by applicable law. Contacts
CTV News
6 minutes ago
- CTV News
S&P/TSX composite falls along with global markets as new U.S. tariffs take effect
A person walks past the TMX Market Centre in Toronto, Wednesday, Sept. 11, 2024. THE CANADIAN PRESS/Paige Taylor White TORONTO — Canada's main stock index was down Friday along with global markets as U.S. President Donald Trump imposed new tariffs on numerous countries and U.S. job numbers showed signs of weakness. The S&P/TSX composite index was down 257.11 points at 27,002.67 in broad losses led by energy. In New York, the Dow Jones industrial average was down 575.39 points at 43,555.59. The S&P 500 index was down 101.80 points at 6,237.59, while the Nasdaq composite was down 449.11 points at 20,673.34. The Canadian dollar traded for 72.53 cents US compared with 72.23 cents US on Thursday. The September crude oil contract was down US$1.82 at US$67.44 per barrel. The December gold contract was up US$54.70 at US$3,362.30 an ounce. --- This report by The Canadian Press was first published Aug.1, 2025.
